Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Stent Length on Short Term Outcomes in Patients With Stable Coronary Disease Undergoing PCI

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03911895
Recruitment Status : Recruiting
First Posted : April 11, 2019
Last Update Posted : April 11, 2019
Sponsor:
Information provided by (Responsible Party):
Mohamed Abd elbaset Hassan, Assiut University

Brief Summary:
Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI

Condition or disease Intervention/treatment
Stable Chronic Angina Device: Stent more than 26 mn length Device: Stent equal to or less than26 mn length

Detailed Description:
Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI. The investigators will follow up patient clinically and use lab investigation.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 1 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Impact of Stent Length on Short Term Outcomes in Patients With Stable Coronary Artery Disease Undergoing PCI
Estimated Study Start Date : July 1, 2019
Estimated Primary Completion Date : June 30, 2020
Estimated Study Completion Date : September 30, 2020

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
patients with coronary artery diseas undergoing PCI
Effect of stent length on patients with coronary artery undergoing PCI
Device: Stent more than 26 mn length
stent length in patients undergoing PCI (Drug Eluting Stent)

Device: Stent equal to or less than26 mn length
stent length in patients undergoing PCI (Drug Eluting Stent)




Primary Outcome Measures :
  1. Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI [ Time Frame: 3 months ]
    to study effect of stent length in patients undergoing PCI



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   25 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Gender Based Eligibility:   Yes
Sampling Method:   Probability Sample
Study Population
Patients with stable coronary artery disease undergoing PCI
Criteria

Inclusion Criteria:

  • patient was CAD referred for elective PC as single vessel

Exclusion Criteria:

  • patients admitted ACS patients with primary PCI PTCA without stenting No complete revascularization PCI-related coronary complication (diessaction,no really)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03911895


Contacts
Layout table for location contacts
Contact: Mohamed Donkol +201002078279 Mohameddonkol141291@gmail.com
Contact: Ahmed Abdel Galeel +201005015156 Ahmed_gelil@yahoo.com

Locations
Layout table for location information
Egypt
Mohamed abdelbast Recruiting
Assiut, Egypt, 23123
Contact: Mohamed Donkol    +201002078279    Mohameddonkol141291@gmail.com   
Sponsors and Collaborators
Assiut University

Layout table for additonal information
Responsible Party: Mohamed Abd elbaset Hassan, Principal investigator, Assiut University
ClinicalTrials.gov Identifier: NCT03911895     History of Changes
Other Study ID Numbers: Stent length impact on PCI
First Posted: April 11, 2019    Key Record Dates
Last Update Posted: April 11, 2019
Last Verified: March 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Device Product Not Approved or Cleared by U.S. FDA: No
Product Manufactured in and Exported from the U.S.: Yes

Additional relevant MeSH terms:
Layout table for MeSH terms
Angina, Stable
Angina Pectoris
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Chest Pain
Pain
Neurologic Manifestations
Signs and Symptoms